EP1131354A4 - Contraceptive antibody vaccines - Google Patents

Contraceptive antibody vaccines

Info

Publication number
EP1131354A4
EP1131354A4 EP99960285A EP99960285A EP1131354A4 EP 1131354 A4 EP1131354 A4 EP 1131354A4 EP 99960285 A EP99960285 A EP 99960285A EP 99960285 A EP99960285 A EP 99960285A EP 1131354 A4 EP1131354 A4 EP 1131354A4
Authority
EP
European Patent Office
Prior art keywords
antibody vaccines
contraceptive antibody
contraceptive
vaccines
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99960285A
Other languages
German (de)
French (fr)
Other versions
EP1131354A1 (en
Inventor
Ronald M Burch
David A Sackler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of EP1131354A1 publication Critical patent/EP1131354A1/en
Publication of EP1131354A4 publication Critical patent/EP1131354A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP99960285A 1998-11-13 1999-11-12 Contraceptive antibody vaccines Withdrawn EP1131354A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10832598P 1998-11-13 1998-11-13
US108325P 1998-11-13
PCT/US1999/026671 WO2000029443A1 (en) 1998-11-13 1999-11-12 Contraceptive antibody vaccines

Publications (2)

Publication Number Publication Date
EP1131354A1 EP1131354A1 (en) 2001-09-12
EP1131354A4 true EP1131354A4 (en) 2003-01-02

Family

ID=22321555

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99960285A Withdrawn EP1131354A4 (en) 1998-11-13 1999-11-12 Contraceptive antibody vaccines

Country Status (7)

Country Link
EP (1) EP1131354A4 (en)
JP (1) JP2003535021A (en)
AU (1) AU753753B2 (en)
CA (1) CA2350917A1 (en)
IL (1) IL143100A0 (en)
MX (1) MXPA01004778A (en)
WO (1) WO2000029443A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081579A1 (en) * 2000-04-05 2001-11-01 Euroceltique S.A. Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis
WO2014052693A2 (en) * 2012-09-29 2014-04-03 The Trustees Of The University Of Pennsylvania Veterinary composition and methods for non-surgical neutering and castration

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508386A (en) * 1989-02-24 1996-04-16 The Regents Of The University Of California Antigenized antibodies and genes
WO1999025378A1 (en) * 1997-11-14 1999-05-27 Euro-Celtique, S.A. Immunoglobulin molecules having a synthetic variable region and modified specificity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436157A (en) * 1989-03-03 1995-07-25 The University Of Virginia Alumni Patents Foundation Human intra-acrosomal sperm antigen
US5208146A (en) * 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
US5637300A (en) * 1994-08-03 1997-06-10 Dunbar; Bonnie S. Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508386A (en) * 1989-02-24 1996-04-16 The Regents Of The University Of California Antigenized antibodies and genes
WO1999025378A1 (en) * 1997-11-14 1999-05-27 Euro-Celtique, S.A. Immunoglobulin molecules having a synthetic variable region and modified specificity

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BRUMEANU T-D ET AL: "Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 2, 1 June 1996 (1996-06-01), pages 85 - 95, XP004052673, ISSN: 1380-2933 *
DIEKMAN ALAN B ET AL: "Sperm antigens and their use in the development of an immunocontraceptive.", AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, vol. 37, no. 1, 1997, pages 111 - 117, XP002049805, ISSN: 1046-7408 *
LANGEDIJK ANNETTE C ET AL: "The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.", JOURNAL OF MOLECULAR BIOLOGY, vol. 283, no. 1, 16 October 1998 (1998-10-16), pages 95 - 110, XP000944533, ISSN: 0022-2836 *
PROBA KARL ET AL: "A natural antibody missing a cysteine in V-H: Consequences for thermodynamic stability and folding.", JOURNAL OF MOLECULAR BIOLOGY, vol. 265, no. 2, 1997, pages 161 - 172, XP002217911, ISSN: 0022-2836 *
RUDIKOFF S ET AL: "Functional antibody lacking a variable-region disulfide bridge", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 83, October 1986 (1986-10-01), pages 7875 - 7878, XP002142019, ISSN: 0027-8424 *
See also references of WO0029443A1 *
ZAGHOUANI H ET AL: "Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 259, no. 5092, 8 January 1993 (1993-01-08), pages 224 - 227, XP002177700, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
MXPA01004778A (en) 2003-07-21
AU753753B2 (en) 2002-10-24
AU1719000A (en) 2000-06-05
WO2000029443A1 (en) 2000-05-25
CA2350917A1 (en) 2000-05-25
WO2000029443A9 (en) 2001-03-22
IL143100A0 (en) 2002-04-21
EP1131354A1 (en) 2001-09-12
JP2003535021A (en) 2003-11-25

Similar Documents

Publication Publication Date Title
GB9809839D0 (en) Antibody
GB9812613D0 (en) Vaccine
GB9806666D0 (en) Antigen preparation and use
HUP0105392A3 (en) Enhanced vaccines
GB9822714D0 (en) Vaccines
PL344519A1 (en) Vaccine
AU8500398A (en) Chimeric contraceptive vaccines
CZ20011896A3 (en) Immunogenic preparation and antibody
GB9828700D0 (en) Antibody
IL143100A0 (en) Contraceptive antibody vaccines
ZA982763B (en) Vaccines
GB9825184D0 (en) Antigen
GB9915419D0 (en) Antigens
GB9800760D0 (en) Antigens
GB9726147D0 (en) Antigens
GB9929923D0 (en) Antigen preparations
GB9819015D0 (en) Antigens
GB9822143D0 (en) Antigens
GB9821821D0 (en) Schistomiasis vaccine
GB9820956D0 (en) Vaccine
GB9807805D0 (en) Vaccine
GB9701487D0 (en) Antigens
GB9816327D0 (en) Antibody
GB9806736D0 (en) Manufactured cellular vaccine
GB9802650D0 (en) Vaccine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010608

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20021115

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20031007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040420